Although these observations have fuelled the idea that inhibiting RBM39 might be a promising therapeutic opportunity for breast cancers, the exact function of RBM39 in cancer in general and in breast cancer in particular remains unclear (15). Here, RBM39 is linked to breast carcinoma.